Quick Answer
Cue Biopharma, Inc. reported Total Assets of $42.21 million for fiscal year 2025.
Cue Biopharma, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $42.21M | +31.1% |
| 2024 | $32.19M | -47.7% |
| 2023 | $61.53M | -32.6% |
| 2022 | $91.28M | +9.5% |
| 2021 | $83.40M | -16.2% |
| 2020 | $99.53M | +39.0% |
| 2019 | $71.61M | +57.8% |
| 2018 | $45.36M | -32.2% |
| 2017 | $66.95M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $31.64M | -29.4% | -22.3% |
| June 30, 2025 | $40.71M | -3.8% | +82.9% |
| March 31, 2025 | $22.25M | -58.8% | -30.9% |
| December 31, 2024 | $32.19M | -47.7% | -28.2% |
| September 30, 2024 | $44.81M | -35.0% | +5.9% |
| June 30, 2024 | $42.33M | -42.1% | -21.5% |
| March 31, 2024 | $53.95M | -33.9% | -12.3% |
| December 31, 2023 | $61.53M | -32.6% | -10.7% |
- Cue Biopharma, Inc. showed an increase of +31.1% in Total Assets compared to the prior fiscal year.
- Over the 2017–2025 period, Cue Biopharma, Inc.’s total assets has declined by 37.0% (from $66.95 million to $42.21 million).
- The most recent figure is from Cue Biopharma, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: